Clinical trials
Completed Lymphoma, B-Cell trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2009 | 2 |
| 2011 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 4 |
| 2020 | 5 |
| 2021 | 2 |
| 2022 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 26 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 2 |
| Peking Union Medical College Hospital | 2 |
| Shanghai Tongji Hospital, Tongji University School of Medicine | 2 |
| BeiGene | 1 |
| Bioray Laboratories | 1 |
| CARsgen Therapeutics Co., Ltd. | 1 |
| Eli Lilly and Company | 1 |
| Eureka Therapeutics Inc. | 1 |
| Fudan University | 1 |
| Gustave Roussy, Cancer Campus, Grand Paris | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, B-Cell | 26 |
| Lymphoma | 4 |
| Lymphoma, Large B-Cell, Diffuse | 4 |
| Lymphoma, Non-Hodgkin | 3 |
| Recurrence | 3 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 |
| Burkitt Lymphoma | 1 |
| Cardiotoxicity | 1 |
| Hematologic Neoplasms | 1 |
| Leukemia, B-Cell | 1 |
Trials
Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.